Success Metrics

Clinical Success Rate
91.7%

Based on 11 completed trials

Completion Rate
92%(11/12)
Active Trials
1(5%)
Results Posted
64%(7 trials)
Terminated
1(5%)

Phase Distribution

Ph not_applicable
8
42%
Ph phase_1
1
5%
Ph phase_2
2
11%
Ph phase_3
1
5%
Ph phase_4
7
37%

Phase Distribution

1

Early Stage

2

Mid Stage

8

Late Stage

Phase Distribution19 total trials
Phase 1Safety & dosage
1(5.3%)
Phase 2Efficacy & side effects
2(10.5%)
Phase 3Large-scale testing
1(5.3%)
Phase 4Post-market surveillance
7(36.8%)
N/ANon-phased studies
8(42.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

84.6%

11 of 13 finished

Non-Completion Rate

15.4%

2 ended early

Currently Active

1

trials recruiting

Total Trials

19

all time

Status Distribution
Active(1)
Completed(11)
Terminated(2)
Other(5)

Detailed Status

Completed11
unknown4
Withdrawn1
Recruiting1
Suspended1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
19
Active
1
Success Rate
91.7%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (5.3%)
Phase 22 (10.5%)
Phase 31 (5.3%)
Phase 47 (36.8%)
N/A8 (42.1%)

Trials by Status

completed1158%
unknown421%
withdrawn15%
recruiting15%
suspended15%
terminated15%

Recent Activity

Clinical Trials (19)

Showing 19 of 19 trials
NCT00582036Not Applicable

Glucose Control In Hematopoetic Stem Cell Transplant

Terminated
NCT07384052Phase 1

Safety and Feasibility of Intranasal Insulin in Patients With Spinal Cord Injury

Recruiting
NCT04074317Phase 2

Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D

Completed
NCT00858897Not Applicable

Glutathione Metabolism in Adolescents With Type 1 Diabetes - Study A

Completed
NCT00858273Not Applicable

Glutathione Metabolism in Adolescents With Type 1 Diabetes - Study B

Completed
NCT04726631Not Applicable

Insulin in Treatment of Diabetes Mellitus With Pregnancy

Completed
NCT03324867Not Applicable

The Effect of Intranasal Insulin Administration on Cognitive Function After Cardiac Surgery.

Unknown
NCT01855243Not Applicable

Comparison on Efficacy and Safety of Three Inpatient Insulin Therapy in Type2 DM

Completed
NCT02006342Not Applicable

Effectiveness of Subcutaneous Glargine On The Time To Closure of The Anion Gap in Patients Presenting to the Emergency Department With Diabetic Keto-acidosis

Completed
NCT01971047Phase 4

Safety and Efficacy Study of Correcting Hyperglycemia in Patients With Diabetes Having Out-patient Surgery

Withdrawn
NCT02607943Phase 3

Insulin Glargine Versus Regular Insulin Based Regimens in Glycemic Control After Acute Stroke

Unknown
NCT02216799Phase 4

Glargine Insulin vs.Continuous Regular Insulin in Diabetic Surgical Patients Receiving Parenteral Nutrition (GLUCOSE-in-PN)

Completed
NCT00596687Phase 4

Basal Bolus Insulin Versus SSRI in Type 2 Diabetes Undergoing General Surgery

Completed
NCT01122979Phase 4

Evaluation of the Safety and Efficacy of Insulin Glargine + Glulisine or Insulin Regular + NPH Insulin (Isophane Insulin) Use in Type 2 Diabetes Mellitus Patients With Moderate Renal Failure.

Completed
NCT01804413Not Applicable

Pegvisomant With Glucagon Test to Assess for Adult Growth Hormone Deficiency

Unknown
NCT00438568Phase 2

SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days)

Completed
NCT01151176Phase 4

Feasible Insulin Algorithm for Glycemic Control in Patients With Acute Coronary Syndrome

Suspended
NCT01143948Phase 4

Various Insulin Regimens for Diabetic Inpatients With Cirrhosis Trial

Unknown
NCT00513201Phase 4

Lyspro Insulin vs Regular Insulin in Cirrhotic Patients

Completed

All 19 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
19